Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$7.96 - $12.37 $849,013 - $1.32 Million
106,660 Added 87.76%
228,198 $2.42 Million
Q4 2023

Jan 24, 2024

SELL
$4.9 - $12.86 $760,543 - $2 Million
-155,213 Reduced 56.08%
121,538 $1.46 Million
Q3 2023

Oct 26, 2023

BUY
$7.0 - $11.26 $143,360 - $230,604
20,480 Added 7.99%
276,751 $1.94 Million
Q2 2023

Aug 10, 2023

BUY
$7.61 - $9.46 $167,077 - $207,694
21,955 Added 9.37%
256,271 $2.18 Million
Q1 2023

May 04, 2023

BUY
$8.83 - $17.61 $152,317 - $303,772
17,250 Added 7.95%
234,316 $2.14 Million
Q4 2022

Feb 09, 2023

SELL
$10.88 - $20.05 $557,143 - $1.03 Million
-51,208 Reduced 19.09%
217,066 $2.48 Million
Q3 2022

Nov 10, 2022

BUY
$16.06 - $26.39 $562,003 - $923,491
34,994 Added 15.0%
268,274 $4.57 Million
Q2 2022

Jul 26, 2022

BUY
$20.49 - $39.72 $1.9 Million - $3.68 Million
92,662 Added 65.9%
233,280 $5.01 Million
Q1 2022

May 10, 2022

SELL
$28.19 - $46.6 $741,848 - $1.23 Million
-26,316 Reduced 15.76%
140,618 $5.2 Million
Q4 2021

Feb 08, 2022

BUY
$41.2 - $73.6 $918,554 - $1.64 Million
22,295 Added 15.41%
166,934 $7.59 Million
Q3 2021

Nov 15, 2021

BUY
$59.15 - $91.99 $1.68 Million - $2.61 Million
28,383 Added 24.41%
144,639 $9.17 Million
Q2 2021

Aug 11, 2021

BUY
$63.02 - $95.11 $589,237 - $889,278
9,350 Added 8.75%
116,256 $10.6 Million
Q1 2021

May 13, 2021

BUY
$57.62 - $95.6 $2.83 Million - $4.7 Million
49,135 Added 85.05%
106,906 $7.28 Million
Q4 2020

Feb 10, 2021

BUY
$41.43 - $77.09 $813,188 - $1.51 Million
19,628 Added 51.46%
57,771 $4.19 Million
Q3 2020

Nov 12, 2020

BUY
$30.88 - $37.94 $362,469 - $445,339
11,738 Added 44.45%
38,143 $1.45 Million
Q2 2020

Aug 11, 2020

BUY
$18.95 - $35.43 $500,374 - $935,529
26,405 New
26,405 $936,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.26B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.